2008, Number 585
<< Back Next >>
Rev Med Cos Cen 2008; 65 (585)
Beneficios del uso de la Aspirina en la Enfermedad Cardiovascular
Zárate EV
Language: Spanish
References: 6
Page: 243-246
PDF size: 177.76 Kb.
ABSTRACT
Atherosclerosis, the major cause of ischemic coronary disease and cerebrovascular disease, is a chronic inflammatory disorder in with immune mechanisms interacts with metabolic risk factors to initiate, propagate and activate vascular lesions. Aspirin use for the primary and secondary prevention of thromboembolic events has a favorable benefit to risk profile and should be encouraged in those at high risk.
REFERENCES
Eidelman R. "An Update on Aspirin in the Primary Prevention of Cardiovascular Disease". Archives of Internal Medicine 2003, 163: 2006-2009.
Goran H. "Inflammation, Atherosclerosis and Coronary Artery Disease". New England Journal of Medicine 2005, 352: 1685-1693.
Patrono C. "Low Dose Aspirin for the Prevention of Atherothomboisis ". New England Journal of Medicine 2005, 353: 2373- 2381.
Persell S. "Aspirin Use among adults with diabetes". Archives of Internal Medicine 2004, 164: 2492-2497.
Ridker P. "A Randomized Trial of Low dose Aspirin in the primary prevention of cardiovascular disease in women". New England Journal of Medicine 2005, 352: 1293-1303.
Weisman S. "Evaluation of the benefits and risks of low dose aspirin in the secondary prevention of cardiovascular events". Archives of Internal Medicine 2002, 162: 2197-2202.
Full text